← Back to headlines





FDA Expedites Review of Psychedelic Drugs for Mental Health Treatment
The FDA has announced new steps to speed up research and review of psychedelic treatments for serious mental health conditions, with initial approvals potentially coming as early as summer, following an executive order.
25 Apr, 00:30 — 25 Apr, 00:30
Related Stories

'Astronauts back on Earth': Artemis II crew splashes down after record-breaking moon flyby – video
just now
Polish Researchers Warn of Nutritional Deficiencies from Weight-Loss Drugs
17m ago
New Fossil Evidence Reveals Giant Prehistoric Octopuses Up to 19 Meters Long
24m ago

NRG Solutions Uses Satellite Data for Urban Building Analysis
24m ago